1. Arranz B, Garriga M, Buisan E, Bernardo M. Impact of the modification of the bioappearance of antipsychotics on therapeutic adherence in patients with schizophrenia: CAPS Study. Rev Psiquiatr Salud Ment (Barc). (January-April 2015);volume 22 issue 1 (1-4p).
2. Huhn M, et al. Lancet 2019;394:939-951.
3. Rummel-Kluge C, et al. Schizophr Res. 2010;123(2–3):225–233.
4. Peuskens J, et al. CNS Drugs. 2014;28(5):421–453.
5. Solid Oral Dosage Form Usage & preference – Lonza study – 2019.
6. Real Decreto Legislativo 1/2015, de 24 de julio, artículo 89.